The effect of Olanzapine on chemotherapy induced nausea and vomiting
Phase 2
Recruiting
- Conditions
- Chemotherapy induced nausea and vomiting.Nausea and vomiting
- Registration Number
- IRCT20170814035697N3
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Age over 18 years old.
Chemotherapy due to cancer for the first time
Exclusion Criteria
Having allergic to olanzapine
Patients under Radiotherapy
Patients with surgical history
Diabetic patients
hyperlipidemia
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The nausea and vomiting severity. Timepoint: The before, first, third and fifth days of chemotherapy. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method